AzTrials
AzTrials

Low Back PainWIPNCT05932043

Development of the Work In Progress Questionnaire

An observational study of Low Back Pain, run by International Institute of Behavioral Medicines at 1 site in Italy.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this study is to describe the development of the Work In Progress questionnaire, a tool designed to evaluate commitment in persons, and its psychometric validation process in the context of low back pain. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Low Back Pain
What is being tested?
This is a non-interventional study
How many people
100 participants
Where
1 siteItaly
Study dates
10 Jul 2023to 29 Feb 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Adult, Older adult

Study population: People with non-specific low back pain. For full description od the condition, please see the definition provided within the references list (Chiarotto A et al).

Who may be able to join

  • Low Back Pain
  • adult age
  • reading/speaking Italian.

Who cannot join

  • systemic illness, mental deficits, recent cerebrovascular accidents or myocardial infarctions, chronic lung or renal diseases;
  • refusal to adhere.

Trial locations and contacts

1 site in 1 country.

Barbara Rocca, BA Psychol contact

39.3333653393

info.ellis.bm@gmail.com

Italy1 site, 1 recruiting
  • Barbara Rocca

    Calosso

    Barbara Rocca

    Recruiting

Other trials in Italy

About this study

Official title: What Can I do for my Low Back Pain? The Work In Progress Questionnaire!

The aim of this study is to describe the development of the Work In Progress questionnaire, a tool designed to evaluate commitment in persons, and its psychometric validation process in the context of low back pain.

Read the detailed description

The study design is cross-sectional.

The following methodology will be applied as for the development of the Work In Progress questionnaire (WIP), a tool designed to evaluate commitment in persons, and its psychometric validation:

  1. item generation and selection: the first defines the content of an index and ensures the most important topics are well-thought-out. The second eliminates redundant items, and decreases the number to a total that is feasible to administer while ensuring the scale measures the construct of interest.
  2. psychometric analysis: exploratory factor analysis (Cattel Scree Test, Varimax Rotation), reliability (internal consistency by Cronbach's alpha, test-retest reliability by Intraclass Correlation Coefficient 2.1), Measurement error (calculated by multiplying the standard error of measurement (SEM) by the z-score associated with the desired level of confidence (95%, in our case) and the square root of 2), and construct validity by hypothesis testing the correlations (Pearson r) with related measures (Pain Catastrophizing Scale, Oswestry Disability Scale, Numerical pain Rating Scale).
Conditions
Low Back Pain
Being tested
This is a non-interventional study
Keywords
outcome measures, commitment, people, psychology, behavioural medicine
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • This is a non-interventional studyDiagnostic test

    None (this is a non-interventional study)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. WIP questionnaire

    Work In Progress questionnaire; score varying from 0 to 30, with higher scores indicating greater commitment

    Measured: At the moment of the questionnaire administration

  2. WIP questionnaire

    Work In Progress questionnaire; score varying from 0 to 30, with higher scores indicating greater commitment

    Measured: After 7-10 days later the first assessment (please, see above) as concerns test-retest assessment reliability.

Secondary outcomes (3)
  1. PCS

    Pain Catastrophizing Scale; score varying from 0 to 52, with higher scores indicating greater catastrophizing

    Measured: At the moment of the questionnaire administration

  2. ODI

    Oswestry Disability Index; score varying from 0 to 50, with higher scores indicating greater disability

    Measured: At the moment of the questionnaire administration

  3. pain NRS

    Numerical pain Rating Scale; score varying from 0 to 10, with higher scores indicating greater pain intensity

    Measured: At the moment of the questionnaire administration

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jul 2023
  2. Study start10 Jul 2023
  3. Primary completion31 Jul 2023
  4. Study completion29 Feb 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
100 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05932043
Sponsor's protocol ID
2023-001
Acronym
WIP
Status last verified
Jan 2024
First submitted
16 Jun 2023
Last updated
10 Jan 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Guyatt GH, Bombardier C, Tugwell PX. Measuring disease-specific quality of life in clinical trials. CMAJ. 1986 Apr 15;134(8):889-95.

    PubMed 3955482
  • Collins D. Pretesting survey instruments: an overview of cognitive methods. Qual Life Res. 2003 May;12(3):229-38. doi: 10.1023/a:1023254226592.

    PubMed 12769135
  • de Vet HCW, Terwee CB, Mokkink LB, et al. Measurement in medicine. A practical guide. Cambridge: Cambridge University Press, 2011

  • Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, Bouter LM, de Vet HC. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007 Jan;60(1):34-42. doi: 10.1016/j.jclinepi.2006.03.012. Epub 2006 Aug 24.

    PubMed 17161752
  • Chiarotto A, Koes BW. Nonspecific Low Back Pain. N Engl J Med. 2022 May 5;386(18):1732-1740. doi: 10.1056/NEJMcp2032396. No abstract available.

    PubMed 35507483
  • Hayes SC. Get out of your mind and into your life: The new acceptance and commitment therapy. New Harbinger Publications; 2005 Nov 1.

  • Sullivan MJ, Bishop SR, & Pivik J. The Pain Catastrophizing Scale: Development and validation. Psychol Assess 1995;7:524-532

  • Fairbank JC, Couper J, Davies JB, O'Brien JP. The Oswestry low back pain disability questionnaire. Physiotherapy. 1980 Aug;66(8):271-3. No abstract available.

    PubMed 6450426
  • Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004 Aug;8(4):283-91. doi: 10.1016/j.ejpain.2003.09.004.

    PubMed 15207508

Questions about this trial

What is this clinical trial studying?

An observational study of Low Back Pain, run by International Institute of Behavioral Medicines at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 10 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Barbara Rocca, BA Psychol (39.3333653393, info.ellis.bm@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

WIP questionnaire (time frame: At the moment of the questionnaire administration). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05932043, which also lists 9 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in